Several issues worthy of attention in clinical research of low rectal cancer
10.19538/j.cjps.issn1005-2208.2019.07.03
- Author:
Hong-wei YAO
1
;
Zhong-tao ZHANG
1
Author Information
1. Department of General Surgery,Beijing Friendship Hospital,Capital Medical University,National Clinical Research Center for Digestive Diseases Beijing 100050,China
- Publication Type:Journal Article
- Keywords:
rectal cancer;
neo-adjuvant chemoradiotherapy;
watch and wait;
lateral lymph node dissection;
transanal total mesorectal excision
- From:
Chinese Journal of Practical Surgery
2019;39(07):655-658
- CountryChina
- Language:Chinese
-
Abstract:
Total mesorectal excision(TME) regulates the extent of resection of low rectal cancer surgery and is the gold standard for low rectal cancer. Colorectal surgeons need to comprehensively consider the comprehensive treatment strategy for rectal cancer to reduce the risk of local recurrence,how to protect patients' anal,sexual and urinary function,and improve their quality of life,and consider how to reduce surgical trauma. At present,the research hotspots in the fieldof rectal cancer diagnosis and treatment turn to how to betterprotect the function and further reduce the risk of localrecurrence. Among them,the "watch and wait" strategy of "clinical complete response" after neoadjuvant chemoradiotherapy,the lateral lymph node dissection and the procedure of transanal total mesorectal excision,is a hot issue in clinical research.